return to news
  1. Nephrocare Health Services IPO Day 1: Check live subscription status, price band, lot size, objectives and key dates

Market News

Nephrocare Health Services IPO Day 1: Check live subscription status, price band, lot size, objectives and key dates

Upstox

3 min read | Updated on December 10, 2025, 16:01 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Nephrocare Health Services IPO Day 1: The ₹871.05 crore initial share sale will conclude on December 12. It is a mix of a fresh issue of shares worth ₹353.4 crore and an offer for sale of 1.12 crore shares aggregating to ₹517.6 crore.

Nephrocare Health Services had a global network of 519 clinics, including 51 clinics across Uzbekistan, the Philippines and Nepal, as of September 2025. | Image: X/@NephroPlus

Nephrocare Health Services had a global network of 519 clinics, including 51 clinics across Uzbekistan, the Philippines and Nepal, as of September 2025. | Image: X/@NephroPlus

Nephrocare Health Services IPO: The initial public offering of dialysis services provider Nephrocare Health Services Limited has been subscribed 11% so far on the first day of bidding on Wednesday, December 10.

Open FREE Demat Account within minutes!
Join now

It received bids for 14,42,848 shares compared to 1,33,87,854 shares on offer, according to the consolidated data on NSE until 4 pm.

CategorySubscription Status
Qualified Institutional Buyers (QIBs)--
Non-Institutional Investors7%
Retail Investors18%
Total11%

The ₹871.05 crore initial share sale will conclude on December 12. The IPO is a mix of a fresh issue of shares worth ₹353.4 crore and an offer for sale of 1.12 crore shares aggregating to ₹517.6 crore.

With a price band of ₹438 to ₹460 per share, a lot consists of 32 shares.

As a part of the OFS, promoters Healthcare Parent, Investcorp Private Equity Fund II, Edoras Investment Holdings Pte and Investcorp Growth Opportunity Fund, along with other shareholders Investcorp India Private Equity Opportunity, 360 One Special Opportunities Funds and International Finance Corporation will divest shares.

The fresh issue proceeds to the tune of ₹129.1 crore for the opening of new dialysis clinics in India, ₹136 crore for debt repayment and the remaining funds for general corporate purposes.

Before the public offer, the company raised ₹260 crore from anchor investors, including SBI Mutual Fund (MF), Fidelity Funds, DSP MF, ICICI Prudential MF, The Prudential Assurance Company, Eastspring Investments, Bandhan MF, Polar Capital Funds, SBI Life Insurance, HDFC Life Insurance and Baroda BNP Paribas MF.

Nephrocare Health Services IPO: Allotment and listing date

EventDate
Subscription periodDecember 10 to December 12
Basis of allotmentDecember 15
Initiation of RefundsDecember 16
Credit of Shares to DematDecember 16
Listing dateDecember 17

About the company

Incorporated in 2009, Nephrocare Health Services Ltd, known for its brand NephroPlus, had a global network of 519 clinics, including 51 clinics across Uzbekistan, Nepal and the Philippines, as of September 30, 2025.

In fiscal 2024, it also expanded into the Saudi Arabia market by forming a joint venture with Arabian International Healthcare Holding Company, an Al Faisaliah Group company. Also, its 165-bed dialysis clinic in Tashkent, Uzbekistan, is the largest dialysis clinic globally.

NephroPlus is also the most widely distributed dialysis network in India, with an extensive pan-India network of clinics across 288 cities, spanning across 21 states and 4 union territories, as of September 2025.

With PTI inputs
To learn more about IPOs, their listings, schedules, and upcoming IPOs, visit our page.

To add Upstox News as your preferred source on Google, click here.
SIP
Consistency beats timing.
promotion image

About The Author

Upstox
Upstox News Desk is a team of journalists who passionately cover stock markets, economy, commodities, latest business trends, and personal finance.

Next Story